Top

International Journal of Colorectal Disease

Published in:

01-09-2007 | Original Article

Lack of association of the 3′-UTR polymorphism in the NFKBIA gene with Crohn’s disease in an Israeli cohort

Authors: E. Leshinsky-Silver, A. Karban, S. Cohen, M. Fridlander, O. Davidowich, G. Kimmel, R. Shamir, A. Levine

Published in: International Journal of Colorectal Disease | Issue 9/2007

Abstract

Background

Crohn’s disease (CD) is a chronic inflammatory disease of the gastrointestinal tract associated with dysregulation of the immune response. It is caused by a combination of environmental and genetic factors. Patients with CD have a TH1-type inflammatory response characterized by nuclear factor kappa B (NFκB) activation. Mutations in the bacterial pattern recognition receptors NOD2/CARD15 and Toll-like receptor 4 (TLR4) genes, which lead to activation of NFκB under normal circumstances, have been associated with increased susceptibility for CD. NFκB plays a critical role in the immune response and is down-regulated by NFκB inhibitor α (NFKBIA). NFKBIA was found to be a susceptibility gene for German CD patients lacking NOD2/CARD15 mutations.

Materials and methods

A cohort of 231 Israeli CD patients previously genotyped for the single nucleotide polymorphisms (SNPs) in the CARD15, TLR4 susceptibility genes for CD, was analyzed for the 3′-untranslated region (UTR) SNP of the NFKBIA gene in comparison to 100 healthy ethnically matched controls. We evaluated the contribution of the 3′-UTR SNP in NFKBIA in patients with or without other SNPs in CARD15 to age of onset, disease location, and disease behavior (Vienna classification).

Results

We did not identify a significant difference in allele and genotype frequencies between either groups or an effect on phenotype. No interactions were found between NFKBIA and any NOD2.

Conclusions

The contribution of population diversity to susceptibility genes for CD plays an important role in disease-associated variants and is important for better understanding of the pathologic mechanisms of the polymorphism.

Hugot JP, Zouali H, Lesage S, Thomas G (1999) Etiology of the inflammatory bowel diseases. Int J Colorectal Dis 14:2–9PubMedCrossRef

Fiocchi C (1998) Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115:182–205PubMedCrossRef

Thompson NP, Driscoll R, Pounder RE, Wakefield AJ (1996) Genetics versus environment in inflammatory bowel disease; results of a British twin study. BMJ 312:95–96PubMed

Sartor JB (1997) Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am J Gastroenterol 92:5S–11SPubMed

Newman B, Siminovitch K (2003) Inflammatory bowel disease: Crohn’s disease and the success of the NODern genetics. Clin Invest Med 26:303–312PubMed

Mathew C, Lewis CM (2004) Genetics of the inflammatory bowel disease: progress and prospects. Hum Mol Genet 13:161–168CrossRef

Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O’Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 411:599–603PubMedCrossRef

Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nunez G, Cho JH (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 411:603–606PubMedCrossRef

Hampe J, Cuthbert A, Croucher PJ, Mirza MM, Mascheretti S, Fisher S, Frenzel H, King K, Hasselmeyer A, MacPherson AJ, Bridger S, van Deventer S, Forbes A, Nikolaus S, Lennard-Jones JE, Foelsch UR, Krawczak M, Lewis C, Schreiber S, Mathew CG (2001) Association between insertion mutation in NOD2 gene and Crohn’s disease in German and British populations. Lancet 357:1925–1928PubMedCrossRef

10.

Inohara N, Nunez G (2001) The NOD: a signaling module that regulates apoptosis and host defense against pathogens. Oncogene 20:6473–6481PubMedCrossRef

11.

Aderem A, Ulevitch RJ (2000) Toll-like receptors in the induction of the innate immune response. Nature 406:782–787PubMedCrossRef

12.

Cario E, Podolsky DK (2000) Differential alternation in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 68:7010PubMedCrossRef

13.

Franchimont D, Vermeire S, El Housni H, Pierik M, Van Steen K, Gustot T, Quertinmont E, Abramowicz M, Van Gossum A, Deviere J, Rutgeerts P (2004) Deficient host–bacteria interactions in inflammatory bowel disease: the toll-like receptor(TLR)-4 Asp299gly polymorphism is associated with Crohn’s disease and ulcerative colitis. Gut 53:987–992PubMedCrossRef

14.

Levine A, Karban A, Eliakim R, Shaoul R, Reif S, Pacht A, Wardi J, Yakir B, Leshinsky-Silver E (2005) A polymorphism in the TNF-α promotor gene is associated with pediatric onset and colonic location of Crohn’s disease. Am J Gastroenterol 100:407–413PubMedCrossRef

15.

Levine A, Raanan A, Wine E, Weiss B, Karban A, Shaoul R, Eliakim R, Reif S, Pacht A, Yakir B, Friedlander M, Kaniel Y, Leshinsky-Silver E (2005) TNF promotor polymorphism and modulation of growth retardation and disease severity in pediatric Crohn’s disease. Am J Gastroenterol 100:1–7CrossRef

16.

Schreiber S, Nikolaus S, Hampe J (1998) Activation of nuclear factor kappa B inflammatory bowel disease. Gut 42:477–484PubMedCrossRef

17.

Rogler G, Brand K, Vogl D, Page S, Hofmeister R, Andus T, Knuechel R, Baeuerle PA, Scholmerich J, Gross V (1998) Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology 15:357–369CrossRef

18.

Neurath MF, Fuss I, Schurmann G, Pettersson S, Arnold K, Muller-Lobeck H, Strober W, Herfarth C, Buschenfelde KH (1998) Cytokine gene transcription by NF-kappa B family members in patients with inflammatory bowel disease. Ann NY Acad Sci 859:149–159PubMedCrossRef

19.

Neurath MF, Pettersson S (1997) Predominant role of NF-kappa B p65 in the pathogenesis of chronic intestinal inflammation. Immunobiology 198:91–98PubMed

20.

Miterski B, Bohringer S, Klein W, Sindern E, Haupts M, Schimrigk S, Epplen JT (2002) Inhibitors in the NFkappaB cascade comprise prime candidate genes predisposing to multiple sclerosis, especially in selected combinations. Genes Immun 3:211–219PubMedCrossRef

21.

Duerr RH, Barmada MM, Zhang L, Pfutzer R, Weeks DE (2000) High-density genome scan in Crohn disease shows confirmed linkage to chromosome 14q11-12. Am J Hum Genet 66:1857–1862PubMedCrossRef

22.

Klein W, Tromm A, Folwaczny C, Hagedorn M, Duerig N, Epplen JT, Wolff H, Schmiegel WH, Griga T (2004) A polymorphism of the NFKBIA gene is associated with Crohn’s disease patients lacking a predisposing allele of the CARD15 gene. Int J Colorectal Dis 19:153–156PubMedCrossRef

23.

Glavac D, Ravnik-Glavac M, O’Brien SJ, Dean M (1994) Polymorphisms in the 3′ untranslated region of the I kappa B/MAD-3 (NFKBI) gene located on chromosome 14. Hum Genet 93:694–696PubMedCrossRef

24.

Zhang K, Deng M, Chen T, Waterman MS, Sun F (2002) A dynamic programming algorithm for haplotype block partitioning. Proc Natl Acad Sci USA 99:7335–7339PubMedCrossRef

25.

Kimmel G, Shamir R (2005) GERBIL: genotype resolution and block identification using likelihood. Proc Natl Acad Sci USA 102:158–162PubMedCrossRef

26.

Wine E, Reif S, Leshinsky-Silver E, Weiss B, Shaoul RR, Shamir R, Wasserman D, Lerner A, Boaz M, LevineA (2004) Pediatric Crohn’s disease and growth retardation: the role of genotype, phenotype, and disease severity. Pediatrics 114:1281–1286PubMedCrossRef

27.

Leshinsky-Silver E, Karban A, Buzhakor E, Yakir B, Eliakim R, Reif S, Shaul R, Boaz M, Lev D, Levine A (2005) Is age of onset of Crohn’s disease governed by mutations in NOD2/CARD15 and Toll-like receptor 4? Evaluation of a pediatric cohort. Pediatr Res 58:499–504PubMedCrossRef

28.

Conne B, Stutz A, Vassalli JD (2000) The 3′-untranslated region of messenger RNA: a molecular hotspot for pathology? Nat Med 6:637–641PubMedCrossRef

29.

Inoue N, Tamura K, Kinouchi Y, Fukuda Y, Takahashi S, Ogura Y, Inohara N, Nunez G, Kishi Y, Koike Y, Shimosegawa T, Shimoyama T, Hibi T (2002) Lack of common NOD2 variants in Japanese patients with Crohn’s disease. Gastroenterology 123:86–91PubMedCrossRef

30.

Yamazaki K, Takazoe M, Tanaka T, Kazumori T, Nakamura Y (2002) Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn’s disease. J Hum Genet 47:469–472PubMedCrossRef

Title: Lack of association of the 3′-UTR polymorphism in the NFKBIA gene with Crohn’s disease in an Israeli cohort
Authors: E. Leshinsky-Silver
A. Karban
S. Cohen
M. Fridlander
O. Davidowich
G. Kimmel
R. Shamir
A. Levine
Publication date: 01-09-2007
Publisher: Springer-Verlag
Published in: International Journal of Colorectal Disease / Issue 9/2007
Print ISSN: 0179-1958
Electronic ISSN: 1432-1262
DOI: https://doi.org/10.1007/s00384-007-0287-x

At a glance: The STEP trials

Springer Medicine

Lack of association of the 3′-UTR polymorphism in the NFKBIA gene with Crohn’s disease in an Israeli cohort

Abstract

Background

Materials and methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Materials and methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 9/2007

Microscopic colitides: a single center experience in Mexico

Autologous fibroblasts transplant after infliximab administration: a new approach in Crohn’s perianal fistulas?

Pyogenic granuloma of the colon

Early re-laparotomy for post-operative complications is a significant risk factor for recurrence after ileocaecal resection for Crohn’s disease

Solitary extramedullary plasmacytoma of anorectum

Ewing’s sarcoma/primitive neuroectodermal tumor (ES/PNET) of the small bowel: a rare cause of intestinal obstruction